| Cell line name |
A375-NTP-R |
|---|
| Accession |
CVCL_C7GI |
|---|
| Resource Identification Initiative |
To cite this cell line use: A375-NTP-R (RRID:CVCL_C7GI) |
|---|
| Comments |
Population: Caucasian.
Selected for resistance to: NCIt; C192869; Non-thermal plasma.
Derived from site: In situ; Skin; UBERON=UBERON_0002097. |
|---|
| Sequence variations |
- Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
- Mutation; HGNC; 1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
- Mutation; HGNC; 1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
- Mutation; HGNC; 11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
|
|---|
| Disease |
Amelanotic melanoma (NCIt: C3802) |
|---|
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
|---|
| Hierarchy |
Parent: CVCL_0132 (A-375) |
|---|
| Sex of cell |
Female |
|---|
| Age at sampling |
54Y |
|---|
| Category |
Cancer cell line |
|---|
| Publications | PubMed=36630862; DOI=10.1016/j.drup.2022.100914
Lin A., Sahun M., Biscop E., Verswyvel H., De Waele J., De Backer J., Theys C., Cuypers B., Laukens K., Vanden Berghe W., Smits E., Bogaerts A.
Acquired non-thermal plasma resistance mediates a shift towards aerobic glycolysis and ferroptotic cell death in melanoma.
Drug Resist. Updat. 67:100914.1-100914.16(2022) |
|---|
| Cross-references |
|---|
| Encyclopedic resources |
Wikidata; Q123030358
|
|---|
| Entry history |
|---|
| Entry creation | 21-Mar-2023 |
|---|
| Last entry update | 30-Jan-2024 |
|---|
| Version number | 3 |
|---|
